Peter Evan Harwin, Director at Apogee Therapeutics, Inc. (APGE), sold 1,750,000 shares at $76.30 ($133.5M) on 2026-01-22, disclosed to the SEC on 2026-01-22.
Open-market sale of $133.5M APGE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZBIO | BUY | 2024-09-16 | $5.1M | — | Filing → |
| DNTH | BUY | 2023-10-03 | $673K | — | Filing → |